| [1] |
.
[J]. Clinical Focus, 2024, 39(11): 1035-1039.
|
| [2] |
Gu Dandan, Zhou Xiaoxian, Wang Jingxian, Wu Chunxiao.
Rectal cap polyposis: A case report and literature review
[J]. Clinical Focus, 2024, 39(9): 828-832.
|
| [3] |
Chen Xiaotian, Huo Lijuan.
Predictive value of serum total bilirubin, neutrophil-to-total bilirubin ratio in evaluating the condition of ulcerative colitis
[J]. Clinical Focus, 2024, 39(7): 603-611.
|
| [4] |
Ren Huaijing, Tao Jianan, Ma Zhenqi, Wang Xuehong.
Colonic telangiectasia combined with bleeding: A case report and literature review
[J]. Clinical Focus, 2024, 39(2): 155-159.
|
| [5] |
Chen Xiaotian, Huo Lijuan.
Meta-analysis of clinical significance of serum total bilirubin level in inflammatory bowel disease
[J]. Clinical Focus, 2023, 38(8): 677-685.
|
| [6] |
Li Lifang, Wang Hongyan.
Respiratory Whipple's disease: A case report and literature review
[J]. Clinical Focus, 2022, 37(12): 1127-1131.
|
| [7] |
Zhang Xiumin, Zhao Changdong, Li Xue, Lu Xuefeng, Liu Weizhong, Wang Shufang.
Relationship between indoleamine 2, 3-dioxygenase and peripheral blood CD4 + in patients with ulcerative colitis
[J]. Clinical Focus, 2021, 36(8): 696-698.
|
| [8] |
Song Yiran, Liang Xiaonan, Li Chenyang, Zhang Xiaolan.
Interpretation on Chinese Expert Consensus of Irritable Bowel Syndrome in 2020
[J]. Clinical Focus, 2021, 36(7): 628-631.
|
| [9] |
.
[J]. Clinical Focus, 2021, 36(5): 467-470.
|
| [10] |
Wang Tingting, Wang Liangzhi.
Expression and clinical significance of apolipoprotein M in inflammatory bowel disease
[J]. Clinical Focus, 2016, 31(1): 53-55.
|
| [11] |
Guo Wenbin,Sun Ximing.
Clinical effect of pernasal catheter in adhesive intestinal obstruction
[J]. Clinical Focus, 2016, 31(1): 85-87.
|
| [12] |
.
[J]. Clinical Focus, 2015, 30(9): 1056-1059.
|
| [13] |
.
@@
[J]. Clinical Focus, 2014, 29(12): 1401-0.
|
| [14] |
.
@@
[J]. Clinical Focus, 2014, 29(12): 1429-1431.
|
| [15] |
ZHENG Xiu-li;FU Xue-song;WANG Yu-gang;ZHANG Yan-hua;ZHAO Xia;LI Hong-yin.
Effect of otilonium bromide combined with probiotics for diarrhea-predominant irritable bowel syndrome
[J]. Clinical Focus, 2014, 29(10): 1168-1170.
|
